Evidence map›Paper›PMID 22761293›Full record

Trial reportBrain : a journal of neurology2012

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke.

Nikos Gorgoraptis, Yee-Haur Mah, Bjoern Machner, Victoria Singh-Curry, Paresh Malhotra, Maria Hadji-Michael, David Cohen, Robert Simister, Ajoy Nair, Elena Kulinskaya and 3 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Brain : a journal of neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 4 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 4 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pharmacological interventions for unilateral spatial neglect after stroke.The Cochrane database of systematic reviews · 2015
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Reversing the Ruin: Rehabilitation, Recovery, and Restoration After Stroke.Current neurology and neuroscience reports · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Neurochemistry of Visual Attention.Frontiers in neuroscience · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Nikos GorgoraptisUCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Yee-Haur Mah
Bjoern Machner
Victoria Singh-Curry
Paresh Malhotra
Maria Hadji-Michael
David Cohen
Robert Simister
Ajoy Nair
Elena Kulinskaya
Nick Ward
Richard Greenwood
Masud Husain
University College London · GBImperial College London · GBHillingdon Hospital · GBHomerton University Hospital · GBNational Hospital for Neurology and Neurosurgery · GBNorthwick Park Hospital · GBUniversity of East Anglia · GBUniversity of Lübeck · DE

Funding

Medical Research Council G0501986Wellcome Trust 098282
6 · The paper itself

Abstract

Hemispatial neglect following right-hemisphere stroke is a common and disabling disorder, for which there is currently no effective pharmacological treatment. Dopamine agonists have been shown to play a role in selective attention and working memory, two core cognitive components of neglect. Here, we investigated whether the dopamine agonist rotigotine would have a beneficial effect on hemispatial neglect in stroke patients. A double-blind, randomized, placebo-controlled ABA design was used, in which each patient was assessed for 20 testing sessions, in three phases: pretreatment (Phase A1), on transdermal rotigotine for 7-11 days (Phase B) and post-treatment (Phase A2), with the exact duration of each phase randomized within limits. Outcome measures included performance on cancellation (visual search), line bisection, visual working memory, selective attention and sustained attention tasks, as well as measures of motor control. Sixteen right-hemisphere stroke patients were recruited, all of whom completed the trial. Performance on the Mesulam shape cancellation task improved significantly while on rotigotine, with the number of targets found on the left side increasing by 12.8% (P = 0.012) on treatment and spatial bias reducing by 8.1% (P = 0.016). This improvement in visual search was associated with an enhancement in selective attention but not on our measures of working memory or sustained attention. The positive effect of rotigotine on visual search was not associated with the degree of preservation of prefrontal cortex and occurred even in patients with significant prefrontal involvement. Rotigotine was not associated with any significant improvement in motor performance. This proof-of-concept study suggests a beneficial role of dopaminergic modulation on visual search and selective attention in patients with hemispatial neglect following stroke.

Indexed as

AdultAgedAged, 80 and overDopamine AgonistsDouble-Blind MethodFemaleFollow-Up StudiesHumansMaleMiddle AgedPerceptual DisordersPsychomotor PerformanceStrokeTetrahydronaphthalenesThiophenesTreatment OutcomeDopamine AgonistsrotigotineTetrahydronaphthalenesThiophenes

Identifiers

PMID22761293
PMCPMC3407421
OpenAlexW2168128813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.